Table 3.
Characteristics | SLNB (n=176) | ALND (n= 180) | P(Chi-square test) |
---|---|---|---|
Mean age ± SD |
52.00 ± 9.61 |
47.00 ± 9.45 |
0.743 |
Axillary recurrence |
|
|
0.420 |
No |
171 |
172 |
|
Yes |
5 |
8 |
|
Recurrence |
|
|
0.049 |
No |
159 |
151 |
|
Yes |
16 |
29 |
|
T stage |
|
|
0.001 |
pT1 |
120 |
86 |
|
pT2 |
45 |
78 |
|
pT3 |
11 |
14 |
|
pT4 |
0 |
2 |
|
N stage |
|
|
0.001 |
pN0 |
127 |
91 |
|
pN1 |
35 |
74 |
|
pN2 |
7 |
6 |
|
pN3 |
7 |
9 |
|
Stage |
|
|
0.001 |
Stage I |
98 |
54 |
|
Stage IIA |
41 |
63 |
|
Stage IIB |
21 |
38 |
|
Stage IIIA |
9 |
15 |
|
Stage IIIB |
0 |
2 |
|
Stage IIIC |
7 |
8 |
|
Size of tumor, cm, mean ± SD |
2.06 ± 1.91 |
2.62 ± 1.70 |
0.019 |
Histology |
|
|
0.013 |
G1 |
47 |
27 |
|
G2 |
73 |
96 |
|
G3 |
43 |
48 |
|
Nuclear |
|
|
0.104 |
G1 |
22 |
20 |
|
G2 |
103 |
90 |
|
G3 |
45 |
65 |
|
ER |
|
|
0.833 |
Negative |
63 |
66 |
|
Positive |
113 |
113 |
|
PR |
|
|
0.311 |
Negative |
71 |
79 |
|
Positive |
105 |
101 |
|
IHC |
|
|
0.525 |
Negative/1+ |
92 |
89 |
|
2+ |
38 |
47 |
|
3+ |
46 |
41 |
|
Lymphovascular invasion |
|
|
0.002 |
No |
113 |
63 |
|
Yes | 86 | 94 |
ER,estrogen receptor; PR,progesterone receptor; IHC,immunohistochemistry.